William Doyle - OptiNose Independent Director
| 0OP Stock | EUR 5.76 0.00 0.00% |
Insider
William Doyle is Independent Director of OptiNose since 2010.
| Age | 56 |
| Tenure | 15 years |
| Phone | 267 364 3500 |
| Web | https://www.optinose.com |
William Doyle Latest Insider Activity
Tracking and analyzing the buying and selling activities of William Doyle against OptiNose stock is an integral part of due diligence when investing in OptiNose. William Doyle insider activity provides valuable insight into whether OptiNose is net buyers or sellers over its current business cycle. Note, OptiNose insiders must abide by specific rules, including filing SEC forms every time they buy or sell OptiNose'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
William Doyle over six months ago Acquisition by William Doyle of 40000 shares of Minerva Neurosciences at 2.9 subject to Rule 16b-3 |
OptiNose Management Efficiency
The company has return on total asset (ROA) of (0.312) % which means that it has lost $0.312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.505) %, meaning that it generated substantial loss on money invested by shareholders. OptiNose's management efficiency ratios could be used to measure how well OptiNose manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Christopher Lohmann | Talanx AG | 55 | |
| John Thuestad | Norsk Hydro ASA | 63 | |
| Bernd Sablowsky | Talanx AG | 53 | |
| Therese Holm | Norsk Hydro ASA | N/A | |
| James Devens | Superior Plus Corp | N/A | |
| Allison Miller | NMI Holdings | N/A | |
| Robert Green | SIVERS SEMICONDUCTORS AB | 60 | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| CCLP CMA | Superior Plus Corp | 62 | |
| Bjorn Norrbom | SIVERS SEMICONDUCTORS AB | 72 | |
| Patric Erlandsson | SIVERS SEMICONDUCTORS AB | 51 | |
| Wilm Langenbach | Talanx AG | 52 | |
| Rick Carron | Superior Plus Corp | N/A | |
| Mike Taylor | Identiv | N/A | |
| Pal Kildemo | Norsk Hydro ASA | 39 | |
| Hilde Aasheim | Norsk Hydro ASA | 65 | |
| Torsten Leue | Talanx AG | 57 | |
| Steven Humphreys | Identiv | 62 | |
| Leigh Dow | Identiv | N/A | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Mohammad Yousaf | NMI Holdings | 47 | |
Management Performance
| Return On Equity | -10.5 | |||
| Return On Asset | -0.31 |
OptiNose Leadership Team
Elected by the shareholders, the OptiNose's board of directors comprises two types of representatives: OptiNose inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OptiNose. The board's role is to monitor OptiNose's management team and ensure that shareholders' interests are well served. OptiNose's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OptiNose's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sandra Helton, Independent Director | ||
| Tomas Heyman, Director | ||
| Anthony Krick, VP Officer | ||
| Ramy Mahmoud, President, Chief Operating Officer | ||
| John Messina, Sr Affairs | ||
| Catherine Owen, Director | ||
| Jonathan Neely, VP Operations | ||
| Joshua Tamaroff, Independent Director | ||
| Joseph Scodari, Independent Chairman of the Board | ||
| Keith Goldan, Chief Financial Officer | ||
| Sriram Venkataraman, Independent Director | ||
| Wilhelmus Groenhuysen, Independent Director | ||
| Peter Miller, Chief Executive Officer, Director | ||
| Michele MBA, VP CFO | ||
| Robert ONeil, Independent Director | ||
| Karen Brophy, Chief HR | ||
| William Doyle, Independent Director | ||
| Michael Esq, Chief Sec | ||
| Victor Clavelli, Chief Commercial Officer | ||
| Per MD, CoFounder AS | ||
| Michael Marino, Chief Legal Officer and Corporate Secretary | ||
| MPH MD, Pres COO |
OptiNose Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OptiNose a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.5 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.97) % | |||
| Operating Margin | (0.76) % | |||
| Current Valuation | 257.48 M | |||
| Shares Outstanding | 111.38 M | |||
| Shares Owned By Insiders | 7.36 % | |||
| Shares Owned By Institutions | 77.80 % | |||
| Price To Book | 23.88 X | |||
| Price To Sales | 2.27 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in OptiNose Stock
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in OptiNose. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in OptiNose Stock please use our How to Invest in OptiNose guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.